Cullinan Oncology, Inc. (CGEM)

Cullinan Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	98.43	156.15	59.77	168.2	63.25	33.83
Short-Term Investments	368.63	311.14	230.69	42.01	35.38	0
Cash & Cash Equivalents	467.07	467.29	290.47	210.21	98.63	33.83
Cash Growth	-0.05%	60.88%	38.18%	113.13%	191.53%	-
Other Current Assets	13.12	7.18	6.1	2.07	1.46	0.39
Total Current Assets	480.19	474.47	296.56	212.28	100.09	34.22
Property, Plant & Equipment	3.53	5.3	0.08	0.13	0.18	0.23
Long-Term Investments	0	80.88	140.4	0	0	0
Other Long-Term Assets	0.46	0.46	0.15	2.3	0.19	0.19
Total Long-Term Assets	3.99	86.65	140.62	2.43	0.37	0.42
Total Assets	484.18	561.12	437.19	214.71	100.46	34.64
Accounts Payable	2.49	2.66	3.17	9.68	0.93	0.3
Current Debt	1.44	1.42	0	0	0	0
Other Current Liabilities	24.2	18.42	8.58	4.64	1.59	1.03
Total Current Liabilities	28.14	22.5	11.75	14.32	2.52	1.32
Long-Term Debt	2.15	3.59	0	0	0	0
Other Long-Term Liabilities	0	0	0.07	0.07	0.07	0.06
Total Long-Term Liabilities	2.15	3.59	0.07	0.07	0.07	0.06
Total Liabilities	30.29	26.09	11.81	14.39	2.6	1.39
Total Debt	3.59	5.01	0	0	0	0
Debt Growth	-28.36%	-	-	-	-	-
Retained Earnings	-200.86	-47.7	-158.91	-93.34	-41.54	-20.87
Comprehensive Income	-0.13	-2.6	-0.84	-0	-0	0
Shareholders' Equity	453.7	535.03	424.97	199.01	-40.77	-20.65
Net Cash / Debt	463.48	462.28	290.47	210.21	98.63	33.83
Net Cash / Debt Growth	0.26%	59.15%	38.18%	113.13%	191.53%	-
Net Cash Per Share	11.15	9.91	6.74	10.57	15.42	13.27
Working Capital	452.05	451.97	284.82	197.96	97.57	32.9
Book Value Per Share	10.92	11.85	9.87	10.01	-6.37	-8.10

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).